Logo image of NOTV

INOTIV INC (NOTV) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:NOTV - US45783Q1004 - Common Stock

0.7642 USD
-0.04 (-4.91%)
Last: 12/12/2025, 8:00:01 PM

NOTV Key Statistics, Chart & Performance

Key Statistics
Market Cap26.26M
Revenue(TTM)N/A
Net Income(TTM)-79.07M
Shares34.36M
Float29.77M
52 Week High6.48
52 Week Low0.66
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-2.22
PEN/A
Fwd PEN/A
Earnings (Next)02-03 2026-02-03
IPO1997-11-25
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


NOTV short term performance overview.The bars show the price performance of NOTV in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

NOTV long term performance overview.The bars show the price performance of NOTV in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of NOTV is 0.7642 USD. In the past month the price decreased by -27.22%. In the past year, price decreased by -87.16%.

INOTIV INC / NOTV Daily stock chart

NOTV Latest News, Press Relases and Analysis

NOTV Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 25.55 215.01B
DHR DANAHER CORP 29.36 159.87B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28 174.99 53.17B
A AGILENT TECHNOLOGIES INC 25.03 39.60B
IQV IQVIA HOLDINGS INC 19.11 37.85B
MTD METTLER-TOLEDO INTERNATIONAL 33.31 28.47B
WAT WATERS CORP 30.34 22.94B
ILMN ILLUMINA INC 30.93 20.61B
WST WEST PHARMACEUTICAL SERVICES 37.84 19.25B
MEDP MEDPACE HOLDINGS INC 39.01 15.72B
TEM TEMPUS AI INC N/A 12.56B
RVTY REVVITY INC 20.98 11.39B

About NOTV

Company Profile

NOTV logo image Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. The company is headquartered in West Lafayette, Indiana and currently employs 1,977 full-time employees. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. The company operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.

Company Info

INOTIV INC

2701 Kent Ave

West Lafayette INDIANA 47906 US

CEO: Robert W. Leasure Jr.

Employees: 1977

NOTV Company Website

NOTV Investor Relations

Phone: 13174634527

INOTIV INC / NOTV FAQ

Can you describe the business of INOTIV INC?

Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. The company is headquartered in West Lafayette, Indiana and currently employs 1,977 full-time employees. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. The company operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.


Can you provide the latest stock price for INOTIV INC?

The current stock price of NOTV is 0.7642 USD. The price decreased by -4.91% in the last trading session.


Does NOTV stock pay dividends?

NOTV does not pay a dividend.


What is the ChartMill technical and fundamental rating of NOTV stock?

NOTV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Is INOTIV INC (NOTV) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NOTV.


What is INOTIV INC worth?

INOTIV INC (NOTV) has a market capitalization of 26.26M USD. This makes NOTV a Nano Cap stock.


What is the ownership structure of INOTIV INC (NOTV)?

You can find the ownership structure of INOTIV INC (NOTV) on the Ownership tab.


NOTV Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

NOTV Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to NOTV. NOTV has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NOTV Financial Highlights

Over the last trailing twelve months NOTV reported a non-GAAP Earnings per Share(EPS) of -2.22. The EPS increased by 47.02% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -10.41%
ROE -54.99%
Debt/Equity 2.73
Chartmill High Growth Momentum
EPS Q2Q%65.75%
Sales Q2Q%5.92%
EPS 1Y (TTM)47.02%
Revenue 1Y (TTM)N/A

NOTV Forecast & Estimates

9 analysts have analysed NOTV and the average price target is 4.93 USD. This implies a price increase of 545.12% is expected in the next year compared to the current price of 0.7642.

For the next year, analysts expect an EPS growth of 17.3% and a revenue growth 4.69% for NOTV


Analysts
Analysts80
Price Target4.93 (545.12%)
EPS Next Y17.3%
Revenue Next Year4.69%

NOTV Ownership

Ownership
Inst Owners23.86%
Ins Owners9.64%
Short Float %6.89%
Short Ratio2.43